Screener

Payments To Acquire Marketing Rights

Name: Eton Pharmaceuticals, Inc. Payments To Acquire Marketing Rights by Products & Services
Creator: OpenCapital
License: https://www.opencapital.sh/terms

Eton Pharmaceuticals, Inc.·Products & Services·2 segments

Breakdown

Segment	Q1 '26
Hemangeol	$14M
Uridine Triacetate	$1M
Total	$14M

Segments

HemangeolView metric

Uridine TriacetateView metric